MAPT and supranuclear palsy, progressive, 1: Irrespective of the clinical presentation, all our cases met established neuropathological diagnostic criteria of PSP with the presence of 4R tau-positive neuronal and glial inclusions, including TAs in a characteristic distribution 20–22.